Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Pilot Study of ATI-2042 in Paroxysmal Atrial Fibrillation with Pacemakers
2004-002996-18Phase 2Unknown
- Sponsor
- ARYx Therapeutics
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of budiodarone in Atrial fibrillation (AFib), sponsored by ARYx Therapeutics. Primary endpoint: AF burden change from baseline. Status: unknown.
02
Drugs
budiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2004-002996-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002996-18.